The fund will primarily invest in medical device, diagnostic, and digital health companies.

Cross-Border Impact Ventures (CBIV), a Canada-based venture capital firm, has raised $30m in the initial close of its Women’s and Children’s Health Technology Fund. The fund will primarily invest in medical device, diagnostic, and digital health companies based in North America, Europe, and Israel. Its secondary focus is on commercial stage companies in emerging markets with global…

The rest of this content is only accessible to Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.